Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.61−0.06 (-8.99%)
Close on Nov 13, 2026Market cap $3.69MP/E –Yield –
Azitra ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Azitra's ebitda for the twelve months ending Sep 30, 2026 was -$12.34M. For fiscal 2025 it was -$10.83M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.83M | – |
| FY2024 | Dec 31, 2024 | -$10.85M | – |
| FY2023 | Dec 31, 2023 | -$7.32M | – |
| FY2022 | Dec 31, 2022 | -$9.33M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.87M | – |
| Q2 FY2026 | Jun 30, 2026 | -$3.38M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.19M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.73M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.84M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.90M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.93M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.44M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.67M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.34M | – |
See a number that looks wrong?